Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
3.150
-0.070 (-2.17%)
Dec 20, 2024, 4:00 PM EST - Market closed
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $316.03 million as of December 20, 2024. Its market cap has decreased by -54.66% in one year.
Market Cap
316.03M
Enterprise Value
-238.97M
1-Year Change
-54.66%
Ranking
Category
Stock Price
$3.15
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $316.03M, a decrease of -81.06%. That is a compound annual growth rate of -63.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 316.03M | -56.48% |
| Dec 29, 2023 | 726.15M | -56.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 323.58M |
| Spok Holdings | 323.55M |
| Corvus Pharmaceuticals | 320.64M |
| Jupiter Neurosciences | 319.89M |
| XOMA Royalty | 319.67M |
| Voyager Therapeutics | 314.10M |
| Trevi Therapeutics | 311.31M |
| Viemed Healthcare | 310.71M |